| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |